Barclays
SRTS icon

Barclays’s Sensus Healthcare SRTS Stock Holding History

Barclays’s Portfolio SRTS Stock Details SRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Hold
2,738
– – ﹤0.01% 4688
2025
Q4 		$10.9K Hold
2,738
– – ﹤0.01% 4927
2025
Q3 		$8.6K Hold
2,738
– – ﹤0.01% 5033
2025
Q2 		$13K Buy
2,738
+869
+46% +$4.07K ﹤0.01% 4896
2025
Q1 		$8.84K Sell
1,869
-3,197
-63% -$18.6K ﹤0.01% 4879
2024
Q4 		$35.1K Buy
+5,066
New +$37.1K ﹤0.01% 4829
2023
Q2 		– Sell
-2,379
Closed -$12.4K – 5052
2023
Q1 		$12.4K Sell
2,379
-3,940
-62% -$28.3K ﹤0.01% 4723
2022
Q4 		$46.9K Buy
6,319
+5,547
+719% +$50K ﹤0.01% 4574
2022
Q3 		$10K Buy
+772
New +$9.22K ﹤0.01% 4314
2018
Q4 		– Sell
-11
Closed – – 7304
2018
Q3 		$0 Buy
+11
New +$80 ﹤0.01% 7373

Other funds holding SRTS

PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
GWM
Greenline Wealth Management Boca Raton, Florida $122M AUM

Barclays's SRTS Position: Q1 2026 in Review

Barclays held its Sensus Healthcare (SRTS) position steady in Q1 2026 at 2,738 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4688.

Barclays first reported a position in SRTS in Q3 2018 and has held it in 10 quarters since. The position peaked at $46.9K in Q4 2022. 41 funds tracked by Wall St. Rank hold SRTS as of Q1 2026.

  • Barclays held 2,738 shares of Sensus Healthcare worth $10.9K as of Q1 2026.
  • Barclays left its Sensus Healthcare share count unchanged in Q1 2026.
  • Sensus Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4688 holding.
  • Barclays first reported a position in Sensus Healthcare in Q3 2018 and has held it in 10 quarters since.
  • Barclays's Sensus Healthcare position peaked at $46.9K in Q4 2022.
  • 41 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.